Reply To: Topic Discussion 2: Corruption in health system

[Soe Wai Yan]

Let me provide my opinion based on Myanmar health system issues:
I agree that defining corruption in health system is difficult because many practices are socially accepted and rarely labelled as corruption, experiencing in Myanmar. Informal payments, favouritism, and absenteeism are often seen as normal responses to a weak system rather than unethical behaviour. However, even when definitions are unclear, I agree with the article that public health professionals should still assess practices based on their impact on equity, patient safety, and trust.
I partly agree the second point that some practices that appear corrupt help keep Myanmar’s fragile health system functioning. Due to low salaries, shortages of medicines, and ongoing political instability, health workers may rely on informal payments or private practice to survive. However, I do not agree that these practices should be tolerated, as they increase inequality and limit access to care for poor and displaced populations.
I agree that conducting research on corruption in Myanmar is extremely challenging. Fear of punishment, lack of transparency, and political sensitivity discourage honest reporting from both health workers and patients. Despite these difficulties, I agree that research is still necessary, as without evidence it is impossible to design effective and context-appropriate anti-corruption strategies.
I partly agree with the concern that studying corruption in Myanmar may be seen as ignoring larger structural problems such as conflict, weak governance, and underfunding of the health sector. However, I do not agree that corruption should be avoided. Corruption worsens these structural problems and directly harms patients, so it must be studied alongside broader political and health system reforms.
In addition to the above points, strengthening transparency in health financing and procurement could help reduce corruption in Myanmar. Limited oversight of medicine supply chains and procurement processes increases the risk of diversion and misuse of resources. Introducing clearer reporting systems (such as real time digital reporting system) and independent monitoring, even at a basic level, could reduce opportunities for corruption and improve access to essential medicines.
Furthermore, supporting decentralised and non-governmental health service delivery may help limit corruption in Myanmar’s current context. Where public systems are weak or disrupted, partnerships with community-based organizations and international agencies can provide alternative accountability structures. This can reduce dependence on informal practices while maintaining access to care for vulnerable populations.